SMARTDUR
RegisteredWord Mark
•
Ownership
CP
Owner Name
Type: Organization / Corporation
Address
Mailcode: 1160, One CVS Drive
Woonsocket, RI 02895
Critical Dates
First Use Date
Mar 1, 2023
Filing Date
Jan 6, 2023
Registration Date
Mar 25, 2025
Mark Descriptions
Services
Class 35
Pharmaceutical cost management services; health care cost review and cost containment services; health care utilization management and review services; medical cost management services; drug utilization review services
Class 44
Clinical and care management services related to prescription fulfillment, namely, preparation of prescriptions and advice regarding prescriptions; clinical and care management services, namely, providing advice regarding adherence and evaluation of therapy plans prior to dispensing of prescriptions...
Mark Elements
Text Mark
SMARTDUR
Category
Service Mark
Standard Characters
Yes
Color Claim
No
Data source: USPTO TSDR
View on USPTO websiteTrademark Timeline
First Use
Filing Date
Publication Date
Registration Date
USPTO Records
| Title | Date | Category | Source | Pages | Format | Actions |
|---|---|---|---|---|---|---|
AI AssessmentCached Mar 12, 2026, 08:24 AMCached
AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.
Trademark Summary
SMARTDUR is a service mark owned by CVS Pharmacy, Inc., a Rhode Island corporation, covering pharmaceutical cost management, health care cost review and containment, utilization management, medical cost management, and drug utilization review services in International Class 035, as well as clinical and care management services for prescription fulfillment, adherence advice, therapy plan evaluation, and medical information on prescriptions in International Class 044. The mark is registered on the Principal Register effective March 25, 2025, with first use and first use in commerce in March 2023. No notable issues or legal proceedings are present.
Recent Activity
Filed on January 6, 2023, the application faced non-final office actions in October 2023 and December 2023, with responses submitted in November 2023 and February 2024, leading to approval and publication for opposition on May 28, 2024. A Notice of Allowance issued on July 23, 2024, followed by a Statement of Use filed on December 18, 2024, which was accepted, resulting in registration on March 25, 2025.
USPTO
AI Analysis
v2.8.0
Never miss important updates for this trademark
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach